Pelthos Therapeutics, Inc. (PTHS)
26.00
+3.26
(+14.34%)
USD |
NYAM |
Apr 08, 12:46
Pelthos Therapeutics Total Assets (Quarterly) : 130.40M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Lifecore Biomedical, Inc. | 232.18M |
| Ligand Pharmaceuticals, Inc. | 1.561B |
| InspireMD, Inc. | 69.40M |
| CytomX Therapeutics, Inc. | 152.50M |
| Cibus, Inc. | 305.05M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 91.52M |
| Shareholders Equity (Quarterly) | 38.88M |
| Debt to Equity Ratio | 0.8958 |
| Current Ratio | 2.027 |
| Net Debt Paydown Yield | -32.51% |